Study of Resolute Coronary Stent System in Treating Diabetic Coronary Lesions
Phase of Trial: Phase IV
Latest Information Update: 20 Nov 2015
At a glance
- Drugs Zotarolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms RESOLUTE-DM
- 31 Aug 2018 Biomarkers information updated
- 16 Nov 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Nov 2013 Planned end date changed from 1 Jun 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov.